Celldex Therapeutics Files Prospectus To Offer 10,345,000 Shares Of Common Stock

Celldex Therapeutics has filed a prospectus to offer 10,345,000 shares of common stock, as reported in their SEC filing. This move is part of their strategy to raise capital, although specific financial details regarding the expected proceeds from the offering were not disclosed.